Healthcare -
Biotechnology - NASDAQ - US
$ 0.881
6.2 %
$ 5.31 M
Market Cap
-0.11
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Dermata Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 12.5 M |
| Operating Income | -12.5 B |
| Other Expenses | -12.5 B |
| Net Income | -12.3 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 322 | 1.36 K |
| Gross Profit | 0 | 0 | 0 | 0 | 322 | 1.36 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 12.5 | 8.0 | 9.7 | 7.9 | 3.2 | 4.5 |
| Selling, General and Administrative Expenses | 4 309.6 | 4.0 | 4.0 | 4.4 | 1.6 | 1.8 |
| Research and Development Expenses | 8 203.7 | 4.1 | 5.7 | 3.5 | 1.6 | 2.6 |
| Operating Income | (12 513.2) | (8.0) | (9.7) | (7.9) | (3.2) | (4.5) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 45.6 K | 0.2 | 0.3 |
| Total Other Income | 225.8 | 0.2 | 63.6 K | 45.6 K | 63.7 K | (0.3) |
| Pre-Tax Income | (12 287.5) | (7.8) | (9.6) | (7.9) | (3.2) | (4.7) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | 9.67 K | 45.6 K | 0.2 | 0.3 |
| Net Income | (12 287.5) | (7.8) | (9.6) | (7.9) | (3.4) | (5.0) |
| EPS | 8.03 K | 40.2 | 13.9 | 15.3 | 6.6 | 9.55 |